Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | SVP and Chief Nursing Officer | November 09, 2021 | November 12, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date November 09, 2021 · Filed November 12, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-11-09 transaction · row 1
1 source rowRow 1 · 2021-11-09 · Sale · Disposed 3,364 · Balance 0 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.60 to $249.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.60 to $249.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2021 Filed Nov 12, 2021 17:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 3,364 | $249.61 | $839,689.05 |
DisclosureSEC source: 0001209191-21-064276 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.60 to $249.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 18:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 7,688 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-21-063265 · doc4.xml · derivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,688 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 18:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 4,324 | $250.00 | $1,081,000.00 |
DisclosureSEC source: 0001209191-21-063265 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,364 Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 18:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 7,688 | $69.58 | $534,931.04 |
DisclosureSEC source: 0001209191-21-063265 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 17:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 4,018 | $250.12 | $1,004,996.62 |
DisclosureSEC source: 0001209191-21-050439 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 19:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 409 | $249.57 | $102,073.31 |
DisclosureSEC source: 0001209191-21-049480 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,018 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.50 to $249.68, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 19:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 2,900 | $249.43 | $723,351.93 |
DisclosureSEC source: 0001209191-21-049480 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,427 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.26 to $249.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 29, 2021 Filed Jul 29, 2021 18:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 200 | $249.36 | $49,872.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · nonDerivative · entry 4 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,327 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.30 to $249.42, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 5,500 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · derivative · entry 7 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 1,925 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · derivative · entry 6 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,925 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 1,375 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · derivative · entry 5 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,375 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 4,782 | $247.69 | $1,184,453.58 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · nonDerivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,527 Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 5,500 | $68.96 | $379,280.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 3,300 | $47.97 | $158,301.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 19:31 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 2,090 | $174.06 | $363,791.88 |
DisclosureSEC source: 0001209191-21-014496 · doc4.xml · nonDerivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,509 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.54 to $174.52, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 19:31 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 3,061 | $175.03 | $535,773.87 |
DisclosureSEC source: 0001209191-21-014496 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,599 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.54 to $175.52, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 19:31 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 600 | $175.75 | $105,448.02 |
DisclosureSEC source: 0001209191-21-014496 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,660 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.58 to $176.00, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,360 | $174.61 | $412,079.60 |
DisclosureSEC source: 0001209191-21-012993 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,260 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 8,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012993 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,620 F1 · kind: On January 31, 2018, the reporting person was granted 4,980 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:25 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 8,370 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008342 · doc4.xml · derivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,370 Underlying: Common Stock · 8,370 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| November 09, 2020 Filed Nov 9, 2020 21:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,745 | $152.50 | $266,112.50 |
DisclosureSEC source: 0001209191-20-057534 · doc4.xml · nonDerivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,509 F1 · kind: The sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 09, 2020 Filed Nov 9, 2020 21:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,745 | $147.00 | $256,515.00 |
DisclosureSEC source: 0001209191-20-057534 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,254 F1 · kind: The sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,745 | $139.50 | $243,427.50 |
DisclosureSEC source: 0001209191-20-057534 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,999 F1 · kind: The sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 18:52 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 5,245 | $132.71 | $696,059.23 |
DisclosureSEC source: 0001209191-20-046664 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,744 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.52 to $132.96, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 1,169 | $150.08 | $175,443.52 |
DisclosureSEC source: 0001209191-20-011756 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,989 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 4,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011756 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,158 F1 · kind: On February 1, 2017, the reporting person was granted 3,970 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 20:27 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 2,063 | $150.00 | $309,450.00 |
DisclosureSEC source: 0001209191-20-007735 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,480 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:35 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 11,040 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005878 · doc4.xml · derivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,040 Underlying: Common Stock · 11,040 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 4,550 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-061973 · doc4.xml · derivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,550 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,487 | $147.53 | $366,907.11 |
DisclosureSEC source: 0001209191-19-061973 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,543 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 4,550 | $37.18 | $169,169.00 |
DisclosureSEC source: 0001209191-19-061973 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 11, 2019 Filed Dec 12, 2019 17:05 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 2,049 | $143.50 | $294,031.50 |
DisclosureSEC source: 0001209191-19-060241 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,480 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 2,100 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-059955 · doc4.xml · derivative · entry 4 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,550 Underlying: Common Stock · 2,100 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 2,450 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-059955 · doc4.xml · derivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,450 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,501 | $144.61 | $361,669.61 |
DisclosureSEC source: 0001209191-19-059955 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,529 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 4,550 | $37.18 | $169,169.00 |
DisclosureSEC source: 0001209191-19-059955 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 18:54 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,995 | $137.50 | $274,312.50 |
DisclosureSEC source: 0001209191-19-056200 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,480 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 18:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 4,550 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-19-055730 · doc4.xml · derivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,450 Underlying: Common Stock · 4,550 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 18:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,555 | $134.34 | $343,238.70 |
DisclosureSEC source: 0001209191-19-055730 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,475 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 18:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 4,550 | $37.18 | $169,169.00 |
DisclosureSEC source: 0001209191-19-055730 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:09 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 634 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014280 · doc4.xml · derivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 634 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 1,268 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:09 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 140 | $143.26 | $20,056.40 |
DisclosureSEC source: 0001209191-19-014280 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,480 Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:09 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-014280 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 1,163 | $142.01 | $165,157.63 |
DisclosureSEC source: 0001209191-19-013226 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,986 Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 4,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013226 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,149 F1 · kind: On January 29, 2016, the reporting person was granted 3,800 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2016-2018. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2016-2018 earnings per share, the number of performance share units that vested equaled 122.25% of the units granted. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 17:27 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 10,670 | $0.00 Strike: $139.06 | $0.00 |
DisclosureSEC source: 0001209191-19-006544 · doc4.xml · derivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,670 Underlying: Common Stock · 10,670 shares Expires 2029-01-30 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020. Read SEC document |
| November 09, 2018 Filed Nov 9, 2018 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 5,081 | $141.90 | $720,993.90 |
DisclosureSEC source: 0001209191-18-058040 · doc4.xml · nonDerivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,504 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-058040 · doc4.xml · derivative · entry 4 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 4,919 | $141.65 | $696,776.35 |
DisclosureSEC source: 0001209191-18-058040 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,585 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 10,000 | $22.95 | $229,500.00 |
DisclosureSEC source: 0001209191-18-058040 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.